Intrinsiqs

Is Rallybio Corporation overvalued?

Rallybio Corporation (RLYB) — key valuation metrics and fundamentals.

No verdict
Price
$16.99
Fair value
Current P/E
Normal P/E
Market cap
$90.2M
Dividend yield
0.0%
Return on equity
68.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares RLYB's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.